Clinical Trials List
2025-08-01 - 2032-03-02
Recruiting5
ICD-10C34.90
Malignant neoplasm of unspecified part of unspecified bronchus or lung
ICD-10C34.91
Malignant neoplasm of unspecified part of right bronchus or lung
ICD-10C34.92
Malignant neoplasm of unspecified part of left bronchus or lung
ICD-10C7A.090
Malignant carcinoid tumor of the bronchus and lung
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.9
Malignant neoplasm of bronchus and lung, unspecified
-
-
Trial Applicant
BRISTOL-MYERS SQUIBB (TAIWAN) LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
Co-Principal Investigator
- 陳昭勳 Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 陳彥勳 Division of Hematology & Oncology
- 黃文聰 Division of Hematology & Oncology
- 高婉真 Division of Hematology & Oncology
- 林建良 Division of Hematology & Oncology
- Shang-Wen Chen Division of Hematology & Oncology
- 曹朝榮 Division of Hematology & Oncology
- 蕭聖諺 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kai-Ling Lee Division of Thoracic Medicine
- Mei-Chuan Chen Division of Thoracic Medicine
- Shang-Fu Hsu Division of Thoracic Medicine
- 高冠鈞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 黃怡菁 Division of Hematology & Oncology
- 蔡政軒 無
- 黃怡璇 Division of Hematology & Oncology
- 鍾秉軒 Division of Hematology & Oncology
- Chin-Wei Kuo 無
- Yu-Min Yeh Division of Hematology & Oncology
- Chien-Chung Lin
- Seu-Chun Yang 無
- Po-Lan Su 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- JIN-YUAN SHIH Division of Hematology & Oncology
- YEN-TING LIN Division of Hematology & Oncology
- 吳尚俊 Division of Hematology & Oncology
- 廖斌志 Division of Hematology & Oncology
- CHAO-CHI HO CHAO-CHI HO Division of Hematology & Oncology
- 許嘉林 Division of Hematology & Oncology
- 蔡子修 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 廖唯昱 Division of Hematology & Oncology
- James Chih-Hsin Yang Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
11 participants
-
Global
590 participants